您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Diacerein(Diacerhein)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Diacerein(Diacerhein)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Diacerein(Diacerhein)图片
CAS NO:13739-02-1
规格:≥98%
包装与价格:
包装价格(元)
25mg电议
50mg电议
100mg电议
250mg电议
500mg电议
1g电议

产品介绍
理化性质和储存条件
Molecular Weight (MW)368.29
FormulaC19H12O8
CAS No.13739-02-1
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: 48 mg/mL (130.3 mM)
Water: <1 mg/mL
Ethanol: <1 mg/mL
Solubility (In vivo)1% CMC Na: 30 mg/mL
SynonymsDiacerhein; Diacetylrhein; DAR; SF 277
实验参考方法
In Vitro

In vitro activity: Diacerein significantly inhibits LPS-induced IL-1beta production by synovial tissue and cartilage. Diacerein (1 μM) has a significantly less inhibitory effect on cartilage synthesis than culture media containing LPS only. Diacerein (1 μM) decreases NO release in synovial tissue and cartilage media and increases IL-1ra levels in cartilage culture media. Diacerein (10 μM) enhances the expression of TGF-beta1 and TGF-beta2 in cultured bovine articular chondrocytes. Diacerein reduces, in a dose-dependent manner, the interleukin-1-beta (IL-1beta)-induced MMP-13 production in osteoarthritic subchondral bone. Diacerein significantly reduces the activity of MMP-13 and cathepsin K in osteoclasts. Diacerein effectively blocks the IL-1beta effect on the osteoclast differentiation process and the survival of mature osteoclasts.

In VivoDiacerein (100 mg/kg/day) significantly suppresses the paw edema and the increase in serum mucoprotein in the adjuvant-induced arthritic rats. Diacerein (30 mg/kg/day) combined with Naproxen (3 mg/kg/day) results in significantly greater anti-inflammatory activity than with naproxen alone in the adjuvant-induced arthritic rats. Diacerein (100 mg/kg/day) also significantly prevents bone loss and reduces the serum alkaline phosphatase and decreases the excretion of urinary hydroxyproline in the ovariectomized rats. Diacerein (25 mg/kg) decreases the thickness of cartilage and subchondral bone in the lesion (middle) zone of the lateral tibial plateau in Merino wethers.
Animal modelRats
Formulation & Dosage30, 100 mg/kg
References

Osteoarthritis Cartilage. 1999 May;7(3):272-80; Osteoarthritis Cartilage. 1999 May;7(3):255-64; Eur J Pharmacol. 2002 Jul 12;448(1):81-7; J Rheumatol. 2001 Apr;28(4):825-34.